Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision banner updated to v3.6.6, replacing v3.6.5. This reflects a page version update without changes to the study content or results.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects an update to the page version.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a newer version of the page published after updates or quality checks.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, indicating a minor update to the page components rather than a change to the study data.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2. This reflects a minor update to page metadata without altering study content or results.SummaryDifference0.1%

- Check97 days agoChange DetectedEnrollment has closed for this study, as indicated by the new 'No longer looking for participants' text. The page also includes updated navigation/help sections and a new version label (v3.6.0) reflecting a refreshed structure.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.